While clinical and medical labs are operating at full capacity due to the Covid-19 pandemic, many other labs and analytics facilities stakeholders have had an opportunity to slow down, innovate, and strategize during lockdown.
This is according to exhibitors set to participate in analytica Lab Africa 2021, South Africa’s only trade show for the laboratory technology, analysis, biotechnology and diagnostics industries.
Delphine Darling, Business Development Director at Lasec, says media reports indicate that medical labs are not coping with the surge in demand for Covid-19 testing, on top of the challenge of backlogs in the supply of certain materials and equipment to Africa. However, she notes: “Laboratories now have a chance to review how they do things in order to strengthen their infrastructure, not only for Covid-19 but also for the future.”
Darryl Harris, General Manager at Shimadzu South Africa, says it has been business as usual for pharmaceutical labs and business unusual for clinical and medical labs, but that many others saw a slowdown in operations during the lockdown. This has given them an opportunity to refocus, strategize and innovate, he says. “We ourselves have used the Click here to read entire article